Abstract
Exosomes are tiny membrane-bound vesicles of various compositions produced in the endosomal compartment of eukaryotic cells. These are secreted as extracellular vesicles and participate in a variety of biological and pathological processes. Exosomes are generally non-immunogenic by nature due to their identical makeup to the cell from which they originate. It gives exosomes substantial advantages over other nanoparticulate drug delivery systems like polymeric nanoparticles and liposomes. This chapter begins with the origin and structure of extracellular vesicles (both exosome and ectosome) and their biological functions. The attention then focuses on specialized uses of exosomes as drug delivery methods in pharmaceutical medication development. The benefits and drawbacks of employing exosomes as pharmaceutical medication delivery vehicles has been discussed. A comprehensive discussion on both the native as well as engineered extracellular vesicles in the application of targeted drug delivery is provided.
This is a preview of subscription content, log in via an institution to check access.
References
Adell MAY, Vogel GF, Pakdel M, Müller M, Lindner H, Hess MW, Teis D. Coordinated binding of Vps4 to ESCRT-III drives membrane neck constriction during MVB vesicle formation. J Cell Biol. 2014;205:33–49. https://doi.org/10.1083/jcb.201310114.
Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJA. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29:341–5. https://doi.org/10.1038/nbt.1807.
Andaloussi SEL, Mäger I, Breakefield XO, Wood MJA. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013;12:347–57. https://doi.org/10.1038/nrd3978.
Andriolo G, Provasi E, Lo Cicero V, Brambilla A, Soncin S, Torre T, Milano G, Biemmi V, Vassalli G, Turchetto L, Barile L, Radrizzani M. Exosomes from human cardiac progenitor cells for therapeutic applications: development of a GMP-grade manufacturing method. Front Physiol. 2018;9:1169.
Batrakova EV, Kim MS. Using exosomes, naturally-equipped nanocarriers, for drug delivery. J Control Release. 2015;219:396–405. https://doi.org/10.1016/j.jconrel.2015.07.030.
Bianco F, Perrotta C, Novellino L, Francolini M, Riganti L, Menna E, Saglietti L, Schuchman EH, Furlan R, Clementi E, Matteoli M, Verderio C. Acid sphingomyelinase activity triggers microparticle release from glial cells. EMBO J. 2009;28:1043–54. https://doi.org/10.1038/emboj.2009.45.
Bissig C, Gruenberg J. ALIX and the multivesicular endosome: ALIX in wonderland. Trends Cell Biol. 2014;24:19–25. https://doi.org/10.1016/j.tcb.2013.10.009.
Buschow SI, Liefhebber JMP, Wubbolts R, Stoorvogel W. Exosomes contain ubiquitinated proteins. Blood Cells Mol Dis. 2005;35:398–403. https://doi.org/10.1016/j.bcmd.2005.08.005.
Cantaluppi V, Biancone L, Figliolini F, Beltramo S, Medica D, Deregibus MC, Galimi F, Romagnoli R, Salizzoni M, Tetta C, Segoloni GP, Camussi G. Microvesicles derived from endothelial progenitor cells enhance neoangiogenesis of human pancreatic islets. Cell Transplant. 2012a;21:1305–20. https://doi.org/10.3727/096368911X627534.
Cantaluppi V, Gatti S, Medica D, Figliolini F, Bruno S, Deregibus MC, Sordi A, Biancone L, Tetta C, Camussi G. Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells. Kidney Int. 2012b;82:412–27. https://doi.org/10.1038/ki.2012.105.
Cashikar AG, Shim S, Roth R, Maldazys MR, Heuser JE, Hanson PI. Structure of cellular ESCRT-III spirals and their relationship to HIV budding. eLife. 2014;3:e02184. https://doi.org/10.7554/eLife.02184.
Chamberlain CS, Clements AEB, Kink JA, Choi U, Baer GS, Halanski MA, Hematti P, Vanderby R. Extracellular vesicle-educated macrophages promote early Achilles tendon healing. Stem Cells. 2019;37:652–62. https://doi.org/10.1002/stem.2988.
Chaput N, Théry C. Exosomes: immune properties and potential clinical implementations. Semin Immunopathol. 2011;33:419–40. https://doi.org/10.1007/s00281-010-0233-9.
Chen TS, Arslan F, Yin Y, Tan SS, Lai RC, Choo ABH, Padmanabhan J, Lee CN, de Kleijn DPV, Lim SK. Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs. J Transl Med. 2011;9:47. https://doi.org/10.1186/1479-5876-9-47.
Chen J, Lu W-L, Gu W, Lu S-S, Chen Z-P, Cai B-C. Skin permeation behavior of elastic liposomes: role of formulation ingredients. Expert Opin Drug Deliv. 2013;10:845–56. https://doi.org/10.1517/17425247.2013.779252.
Chen Y, Buyel JJ, Hanssen MJW, Siegel F, Pan R, Naumann J, Schell M, van der Lans A, Schlein C, Froehlich H, Heeren J, Virtanen KA, van MarkenLichtenbelt W, Pfeifer A. Exosomal microRNA miR-92a concentration in serum reflects human brown fat activity. Nat Commun. 2016;7:11420. https://doi.org/10.1038/ncomms11420.
Clayton A, Turkes A, Dewitt S, Steadman R, Mason MD, Hallett MB. Adhesion and signaling by B cell-derived exosomes: the role of integrins. FASEB J. 2004;18:977–9. https://doi.org/10.1096/fj.03-1094fje.
Cocucci E, Meldolesi J. Ectosomes and exosomes: shedding the confusion between extracellular vesicles. Trends Cell Biol. 2015;25:364–72. https://doi.org/10.1016/j.tcb.2015.01.004.
Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol. 2009;19:43–51. https://doi.org/10.1016/j.tcb.2008.11.003.
Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, Becker A, Hoshino A, Mark MT, Molina H, **ang J, Zhang T, Theilen T-M, García-Santos G, Williams C, Ararso Y, Huang Y, Rodrigues G, Shen T-L, Labori KJ, Lothe IMB, Kure EH, Hernandez J, Doussot A, Ebbesen SH, Grandgenett PM, Hollingsworth MA, Jain M, Mallya K, Batra SK, Jarnagin WR, Schwartz RE, Matei I, Peinado H, Stanger BZ, Bromberg J, Lyden D. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol. 2015;17:816–26. https://doi.org/10.1038/ncb3169.
Datta B, Paul D, Pal U, Rakshit T. Intriguing biomedical applications of synthetic and natural cell-derived vesicles: a comparative overview. ACS Appl Bio Mater. 2021;4:2863–85. https://doi.org/10.1021/acsabm.0c01480.
Dubyak GR. P2X7 receptor regulation of non-classical secretion from immune effector cells. Cell Microbiol. 2012;14:1697–706. https://doi.org/10.1111/cmi.12001.
Eken C, Sadallah S, Martin PJ, Treves S, Schifferli JA. Ectosomes of polymorphonuclear neutrophils activate multiple signaling pathways in macrophages. Immunobiology. 2013;218:382–92. https://doi.org/10.1016/j.imbio.2012.05.021.
Ekström EJ, Bergenfelz C, von Bülow V, Serifler F, Carlemalm E, Jönsson G, Andersson T, Leandersson K. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells. Mol Cancer. 2014;13:88. https://doi.org/10.1186/1476-4598-13-88.
Fabrikant G, Lata S, Riches JD, Briggs JAG, Weissenhorn W, Kozlov MM. Computational model of membrane fission catalyzed by ESCRT-III. PLoS Comput Biol. 2009;5:e1000575. https://doi.org/10.1371/journal.pcbi.1000575.
Feng Y, Huang W, Meng W, Jegga AG, Wang Y, Cai W, Kim HW, Pasha Z, Wen Z, Rao F, Modi RM, Yu X, Ashraf M. Heat shock improves Sca-1+ stem cell survival and directs ischemic cardiomyocytes toward a prosurvival phenotype via exosomal transfer: a critical role for HSF1/miR-34a/HSP70 pathway. Stem Cells. 2014;32:462–72. https://doi.org/10.1002/stem.1571.
Fitts CA, Ji N, Li Y, Tan C. Exploiting exosomes in cancer liquid biopsies and drug delivery. Adv Healthc Mater. 2019;8:1801268. https://doi.org/10.1002/adhm.201801268.
Fuhrmann G, Serio A, Mazo M, Nair R, Stevens MM. Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. J Control Release. 2015;205:35–44. https://doi.org/10.1016/j.jconrel.2014.11.029.
Gardiner C, Di Vizio D, Sahoo S, Théry C, Witwer KW, Wauben M, Hill AF. Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey. J Extracell Vesicles. 2016;5:32945. https://doi.org/10.3402/jev.v5.32945.
Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, Noiseux N, Zhang L, Pratt RE, Ingwall JS, Dzau VJ. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med. 2005;11:367–8. https://doi.org/10.1038/nm0405-367.
Gnecchi M, He H, Noiseux N, Liang OD, Zhang L, Morello F, Mu H, Melo LG, Pratt RE, Ingwall JS, Dzau VJ. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 2006;20:661–9. https://doi.org/10.1096/fj.05-5211com.
György B, Szabó TG, Pásztói M, Pál Z, Misják P, Aradi B, László V, Pállinger E, Pap E, Kittel A, Nagy G, Falus A, Buzás EI. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci. 2011;68:2667–88. https://doi.org/10.1007/s00018-011-0689-3.
Haney MJ, Klyachko NL, Zhao Y, Gupta R, Plotnikova EG, He Z, Patel T, Piroyan A, Sokolsky M, Kabanov AV, Batrakova EV. Exosomes as drug delivery vehicles for Parkinson’s disease therapy. J Control Release. 2015;207:18–30. https://doi.org/10.1016/j.jconrel.2015.03.033.
Harding C, Heuser J, Stahl P. Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J Cell Biol. 1983;97:329–39. https://doi.org/10.1083/jcb.97.2.329.
Harding C, Heuser J, Stahl P. Endocytosis and intracellular processing of transferrin and colloidal gold-transferrin in rat reticulocytes: demonstration of a pathway for receptor shedding. Eur J Cell Biol. 1984;35:256–63.
Hartjes TA, Mytnyk S, Jenster GW, van Steijn V, van Royen ME. Extracellular vesicle quantification and characterization: common methods and emerging approaches. Bioengineering (Basel). 2019;6:E7. https://doi.org/10.3390/bioengineering6010007.
He C, Zheng S, Luo Y, Wang B. Exosome theranostics: biology and translational medicine. Theranostics. 2018;8:237–55. https://doi.org/10.7150/thno.21945.
Hsu C, Morohashi Y, Yoshimura S-I, Manrique-Hoyos N, Jung S, Lauterbach MA, Bakhti M, Grønborg M, Möbius W, Rhee J, Barr FA, Simons M. Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C. J Cell Biol. 2010;189:223–32. https://doi.org/10.1083/jcb.200911018.
Huang Q, Chen H, Li J, Oliver M, Ma X, Byck D, Gao Y, Jiang S-W. Epigenetic and non-epigenetic regulation of syncytin-1 expression in human placenta and cancer tissues. Cell Signal. 2014;26:648–56. https://doi.org/10.1016/j.cellsig.2013.11.002.
Hwang DW, Jo MJ, Lee JH, Kang H, Bao K, Hu S, Baek Y, Moon HG, Lee DS, Kashiwagi S. Chemical modulation of bioengineered exosomes for tissue-specific biodistribution. Adv Therapeut. 2019;2:1900111. https://doi.org/10.1002/adtp.201900111.
Jang SC, Kim OY, Yoon CM, Choi D-S, Roh T-Y, Park J, Nilsson J, Lötvall J, Kim Y-K, Gho YS. Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. ACS Nano. 2013;7:7698–710. https://doi.org/10.1021/nn402232g.
Jia G, Han Y, An Y, Ding Y, He C, Wang X, Tang Q. NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo. Biomaterials. 2018;178:302–16. https://doi.org/10.1016/j.biomaterials.2018.06.029.
**g B, Gai Y, Qian R, Liu Z, Zhu Z, Gao Y, Lan X, An R. Hydrophobic insertion-based engineering of tumor cell-derived exosomes for SPECT/NIRF imaging of colon cancer. J Nanobiotechnol. 2021;19:7. https://doi.org/10.1186/s12951-020-00746-8.
Khan M, Nickoloff E, Abramova T, Johnson J, Verma SK, Krishnamurthy P, Mackie AR, Vaughan E, Garikipati VNS, Benedict C, Ramirez V, Lambers E, Ito A, Gao E, Misener S, Luongo T, Elrod J, Qin G, Houser SR, Koch WJ, Kishore R. Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction. Circ Res. 2015;117:52–64. https://doi.org/10.1161/CIRCRESAHA.117.305990.
Kim MS, Haney MJ, Zhao Y, Mahajan V, Deygen I, Klyachko NL, Inskoe E, Piroyan A, Sokolsky M, Okolie O, Hingtgen SD, Kabanov AV, Batrakova EV. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomedicine. 2016;12:655–64. https://doi.org/10.1016/j.nano.2015.10.012.
Kordelas L, Rebmann V, Ludwig A-K, Radtke S, Ruesing J, Doeppner TR, Epple M, Horn PA, Beelen DW, Giebel B. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia. 2014;28:970–3. https://doi.org/10.1038/leu.2014.41.
Kunder CA, St. John AL, Li G, Leong KW, Berwin B, Staats HF, Abraham SN. Mast cell–derived particles deliver peripheral signals to remote lymph nodes. J Exp Med. 2009;206:2455–67. https://doi.org/10.1084/jem.20090805.
Lai X, Wang M, McElyea SD, Sherman S, House M, Korc M. A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer. Cancer Lett. 2017;393:86–93. https://doi.org/10.1016/j.canlet.2017.02.019.
Lamparski HG, Metha-Damani A, Yao J-Y, Patel S, Hsu D-H, Ruegg C, Le Pecq J-B. Production and characterization of clinical grade exosomes derived from dendritic cells. J Immunol Methods. 2002;270:211–26. https://doi.org/10.1016/S0022-1759(02)00330-7.
Lata S, Schoehn G, Jain A, Pires R, Piehler J, Gottlinger HG, Weissenhorn W. Helical structures of ESCRT-III are disassembled by VPS4. Science. 2008;321:1354–7. https://doi.org/10.1126/science.1161070.
Lee Y, Andaloussi ELS, Wood MJA. Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet. 2012;21:R125–34. https://doi.org/10.1093/hmg/dds317.
Lee J, Kim J, Jeong M, Lee H, Goh U, Kim H, Kim B, Park J-H. Liposome-based engineering of cells to package hydrophobic compounds in membrane vesicles for tumor penetration. Nano Lett. 2015;15:2938–44. https://doi.org/10.1021/nl5047494.
Lee H, Park H, Noh GJ, Lee ES. pH-responsive hyaluronate-anchored extracellular vesicles to promote tumor-targeted drug delivery. Carbohydr Polym. 2018;202:323–33. https://doi.org/10.1016/j.carbpol.2018.08.141.
Lenz M, Crow DJG, Joanny J-F. Membrane buckling induced by curved filaments. Phys Rev Lett. 2009;103:038101. https://doi.org/10.1103/PhysRevLett.103.038101.
Li J, Liu K, Liu Y, Xu Y, Zhang F, Yang H, Liu J, Pan T, Chen J, Wu M, Zhou X, Yuan Z. Exosomes mediate the cell-to-cell transmission of IFN-α-induced antiviral activity. Nat Immunol. 2013;14:793–803. https://doi.org/10.1038/ni.2647.
Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J, Chen D, Gu J, He X, Huang S. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res. 2015;25:981–4. https://doi.org/10.1038/cr.2015.82.
Li P, Kaslan M, Lee SH, Yao J, Gao Z. Progress in exosome isolation techniques. Theranostics. 2017;7:789–804. https://doi.org/10.7150/thno.18133.
Liao C-F, Lin S-H, Chen H-C, Tai C-J, Chang C-C, Li L-T, Yeh C-M, Yeh K-T, Chen Y-C, Hsu T-H, Shen S-C, Lee W-R, Chiou J-F, Luo S-F, Jiang M-C. CSE1L, a novel microvesicle membrane protein, mediates Ras-triggered microvesicle generation and metastasis of tumor cells. Mol Med. 2012;18:1269–80. https://doi.org/10.2119/molmed.2012.00205.
Liu C, Su C. Design strategies and application progress of therapeutic exosomes. Theranostics. 2019;9:1015. https://doi.org/10.7150/thno.30853.
Logozzi M, De Milito A, Lugini L, Borghi M, Calabrò L, Spada M, Perdicchio M, Marino ML, Federici C, Iessi E, Brambilla D, Venturi G, Lozupone F, Santinami M, Huber V, Maio M, Rivoltini L, Fais S. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS One. 2009;4:e5219. https://doi.org/10.1371/journal.pone.0005219.
Lösche W, Scholz T, Temmler U, Oberle V, Claus RA. Platelet-derived microvesicles transfer tissue factor to monocytes but not to neutrophils. Platelets. 2004;15:109–15. https://doi.org/10.1080/09537100310001649885.
Luzio JP, Parkinson MDJ, Gray SR, Bright NA. The delivery of endocytosed cargo to lysosomes. Biochem Soc Trans. 2009;37:1019–21. https://doi.org/10.1042/BST0371019.
Luzio JP, Gray SR, Bright NA. Endosome–lysosome fusion. Biochem Soc Trans. 2010;38:1413–6. https://doi.org/10.1042/BST0381413.
Machida T, Tomofuji T, Ekuni D, Maruyama T, Yoneda T, Kawabata Y, Mizuno H, Miyai H, Kunitomo M, Morita M. MicroRNAs in salivary exosome as potential biomarkers of aging. Int J Mol Sci. 2015;16:21294–309. https://doi.org/10.3390/ijms160921294.
Maguire G. Stem cell therapy without the cells. Commun Integr Biol. 2013;6:e26631. https://doi.org/10.4161/cib.26631.
Mege D, Panicot-Dubois L, Ouaissi M, Robert S, Sielezneff I, Sastre B, Dignat-George F, Dubois C. The origin and concentration of circulating microparticles differ according to cancer type and evolution: a prospective single-center study. Int J Cancer. 2016;138:939–48. https://doi.org/10.1002/ijc.29837.
Melo SA, Luecke LB, Kahlert C, Fernandez AF, Gammon ST, Kaye J, LeBleu VS, Mittendorf EA, Weitz J, Rahbari N, Reissfelder C, Pilarsky C, Fraga MF, Piwnica-Worms D, Kalluri R. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature. 2015;523:177–82. https://doi.org/10.1038/nature14581.
Mendt M, Kamerkar S, Sugimoto H, McAndrews KM, Wu C-C, Gagea M, Yang S, Blanko EVR, Peng Q, Ma X, Marszalek JR, Maitra A, Yee C, Rezvani K, Shpall E, LeBleu VS, Kalluri R. Generation and testing of clinical-grade exosomes for pancreatic cancer. JCI Insight. 2018;3:99263. https://doi.org/10.1172/jci.insight.99263.
Meng W, He C, Hao Y, Wang L, Li L, Zhu G. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source. Drug Deliv. 2020;27:585–98. https://doi.org/10.1080/10717544.2020.1748758.
Morel O, Jesel L, Freyssinet J-M, Toti F. Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol. 2011;31:15–26. https://doi.org/10.1161/ATVBAHA.109.200956.
Munson P, Shukla A. Exosomes: potential in cancer diagnosis and therapy. Medicines (Basel). 2015;2:310–27. https://doi.org/10.3390/medicines2040310.
Muralidharan-Chari V, Clancy JW, Sedgwick A, D’Souza-Schorey C. Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci. 2010;123:1603–11. https://doi.org/10.1242/jcs.064386.
Nakase I, Futaki S. Combined treatment with a pH-sensitive fusogenic peptide and cationic lipids achieves enhanced cytosolic delivery of exosomes. Sci Rep. 2015;5:1–13. https://doi.org/10.1038/srep10112.
Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, Moita CF, Schauer K, Hume AN, Freitas RP, Goud B, Benaroch P, Hacohen N, Fukuda M, Desnos C, Seabra MC, Darchen F, Amigorena S, Moita LF, Thery C. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2010;12:19–30. https://doi.org/10.1038/ncb2000.
Owens AP, Mackman N. Microparticles in hemostasis and thrombosis. Circ Res. 2011;108:1284–97. https://doi.org/10.1161/CIRCRESAHA.110.233056.
Pachler K, Lener T, Streif D, Dunai ZA, Desgeorges A, Feichtner M, Öller M, Schallmoser K, Rohde E, Gimona M. A good manufacturing practice–grade standard protocol for exclusively human mesenchymal stromal cell–derived extracellular vesicles. Cytotherapy. 2017;19:458–72. https://doi.org/10.1016/j.jcyt.2017.01.001.
Pan B-T, Johnstone RM. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell. 1983;33:967–78. https://doi.org/10.1016/0092-8674(83)90040-5.
Pan BT, Teng K, Wu C, Adam M, Johnstone RM. Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J Cell Biol. 1985;101:942–8. https://doi.org/10.1083/jcb.101.3.942.
Pascucci L, Coccè V, Bonomi A, Ami D, Ceccarelli P, Ciusani E, Viganò L, Locatelli A, Sisto F, Doglia SM, Parati E, Bernardo ME, Muraca M, Alessandri G, Bondiolotti G, Pessina A. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. J Control Release. 2014;192:262–70. https://doi.org/10.1016/j.jconrel.2014.07.042.
Phinney DG, Pittenger MF. Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells. 2017;35:851–8. https://doi.org/10.1002/stem.2575.
Pramanik SK, Pal U, Choudhary P, Singh H, Reiter RJ, Ethirajan A, Swarnakar S, Das S. Stimuli-responsive nanocapsules for the spatiotemporal release of melatonin: protection against gastric inflammation. ACS Appl Bio Mater. 2019;2:5218–26. https://doi.org/10.1021/acsabm.9b00236.
Qi H, Liu C, Long L, Ren Y, Zhang S, Chang X, Qian X, Jia H, Zhao J, Sun J, Hou X, Yuan X, Kang C. Blood exosomes endowed with magnetic and targeting properties for cancer therapy. ACS Nano. 2016;10:3323–33. https://doi.org/10.1021/acsnano.5b06939.
Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, Geuze HJ. B lymphocytes secrete antigen-presenting vesicles. J Exp Med. 1996;183:1161–72. https://doi.org/10.1084/jem.183.3.1161.
Rilla K, Pasonen-Seppänen S, Deen AJ, Koistinen VVT, Wojciechowski S, Oikari S, Kärnä R, Bart G, Törrönen K, Tammi RH, Tammi MI. Hyaluronan production enhances shedding of plasma membrane-derived microvesicles. Exp Cell Res. 2013;319:2006–18. https://doi.org/10.1016/j.yexcr.2013.05.021.
Saksena S, Wahlman J, Teis D, Johnson AE, Emr SD. Functional reconstitution of ESCRT-III assembly and disassembly. Cell. 2009;136:97–109. https://doi.org/10.1016/j.cell.2008.11.013.
Sato YT, Umezaki K, Sawada S, Mukai S, Sasaki Y, Harada N, Shiku H, Akiyoshi K. Engineering hybrid exosomes by membrane fusion with liposomes. Sci Rep. 2016;6:21933. https://doi.org/10.1038/srep21933.
Shifrin DA, DemoryBeckler M, Coffey RJ, Tyska MJ. Extracellular vesicles: communication, coercion, and conditioning. Mol Biol Cell. 2013;24:1253–9. https://doi.org/10.1091/mbc.E12-08-0572.
Stein JM, Luzio JP. Ectocytosis caused by sublytic autologous complement attack on human neutrophils. The sorting of endogenous plasma-membrane proteins and lipids into shed vesicles. Biochem J. 1991;274:381–6. https://doi.org/10.1042/bj2740381.
Tamura R, Uemoto S, Tabata Y. Augmented liver targeting of exosomes by surface modification with cationized pullulan. Acta Biomater. 2017;57:274–84. https://doi.org/10.1016/j.actbio.2017.05.013.
Tan CY, Lai RC, Wong W, Dan YY, Lim S-K, Ho HK. Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models. Stem Cell Res Ther. 2014;5:76. https://doi.org/10.1186/scrt465.
Théry C, Boussac M, Véron P, Ricciardi-Castagnoli P, Raposo G, Garin J, Amigorena S. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol. 2001;166:7309–18. https://doi.org/10.4049/jimmunol.166.12.7309.
Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7:1535750. https://doi.org/10.1080/20013078.2018.1535750.
Tian Y, Li S, Song J, Ji T, Zhu M, Anderson GJ, Wei J, Nie G. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials. 2014;35:2383–90. https://doi.org/10.1016/j.biomaterials.2013.11.083.
Timmers L, Lim SK, Hoefer IE, Arslan F, Lai RC, van Oorschot AAM, Goumans MJ, Strijder C, Sze SK, Choo A, Piek JJ, Doevendans PA, Pasterkamp G, de Kleijn DPV. Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem Cell Res. 2011;6:206–14. https://doi.org/10.1016/j.scr.2011.01.001.
Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, Schwille P, Brügger B, Simons M. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 2008;319:1244–7. https://doi.org/10.1126/science.1153124.
van der Pol E, Coumans F, Varga Z, Krumrey M, Nieuwland R. Innovation in detection of microparticles and exosomes. J Thromb Haemost. 2013;11(Suppl 1):36–45. https://doi.org/10.1111/jth.12254.
Wang J, Zhou Y, Lu J, Sun Y, **ao H, Liu M, Tian L. Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic and prognostic biomarkers for laryngeal squamous cell carcinoma. Med Oncol. 2014;31:148. https://doi.org/10.1007/s12032-014-0148-8.
Yang J-M, Gould SJ. The cis-acting signals that target proteins to exosomes and microvesicles. Biochem Soc Trans. 2013;41:277–82. https://doi.org/10.1042/BST20120275.
Yang Y, Hong Y, Nam G-H, Chung JH, Koh E, Kim I-S. Virus-mimetic Fusogenic exosomes for direct delivery of integral membrane proteins to target cell membranes. Adv Mater. 2017;29. https://doi.org/10.1002/adma.201605604.
Yu B, Du Q, Li H, Liu H-Y, Ye X, Zhu B, Zhai Q, Li X-X. Diagnostic potential of serum exosomal colorectal neoplasia differentially expressed long non-coding RNA (CRNDE-p) and microRNA-217 expression in colorectal carcinoma. Oncotarget. 2017;8:83745–53. https://doi.org/10.18632/oncotarget.19407.
Zhang W, Zhao P, Xu X-L, Cai L, Song Z-S, Cao D-Y, Tao K-S, Zhou W-P, Chen Z-N, Dou K-F. Annexin A2 promotes the migration and invasion of human hepatocellular carcinoma cells in vitro by regulating the shedding of CD147-harboring microvesicles from tumor cells. PLoS One. 2013;8:e67268. https://doi.org/10.1371/journal.pone.0067268.
Zhang X, Yuan X, Shi H, Wu L, Qian H, Xu W. Exosomes in cancer: small particle, big player. J Hematol Oncol. 2015;8:83. https://doi.org/10.1186/s13045-015-0181-x.
Zhang W, Zhou X, Zhang H, Yao Q, Liu Y, Dong Z. Extracellular vesicles in diagnosis and therapy of kidney diseases. Am J Physiol Renal Physiol. 2016;311:F844–51. https://doi.org/10.1152/ajprenal.00429.2016.
Zhang Y, Hu Y-W, Zheng L, Wang Q. Characteristics and roles of exosomes in cardiovascular disease. DNA Cell Biol. 2017;36:202–11. https://doi.org/10.1089/dna.2016.3496.
Zhao C, Busch DJ, Vershel CP, Stachowiak JC. Multifunctional transmembrane protein ligands for cell-specific targeting of plasma membrane-derived vesicles. Small. 2016;12:3837–48. https://doi.org/10.1002/smll.201600493.
Zhu X, Badawi M, Pomeroy S, Sutaria DS, **e Z, Baek A, Jiang J, Elgamal OA, Mo X, Perle KL, Chalmers J, Schmittgen TD, Phelps MA. Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells. J Extracell Vesicles. 2017;6:1324730. https://doi.org/10.1080/20013078.2017.1324730.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this entry
Cite this entry
Ghosh, D., Rudra, D.S., Pal, U. (2023). Cell-Derived Exosome-Based Materials for Biomedical Applications. In: Maia, F.R.A., Oliveira, J.M., Reis, R.L. (eds) Handbook of the Extracellular Matrix. Springer, Cham. https://doi.org/10.1007/978-3-030-92090-6_35-2
Download citation
DOI: https://doi.org/10.1007/978-3-030-92090-6_35-2
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-92090-6
Online ISBN: 978-3-030-92090-6
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences
Publish with us
Chapter history
-
Latest
Cell-Derived Exosome-Based Materials for Biomedical Applications- Published:
- 04 March 2024
DOI: https://doi.org/10.1007/978-3-030-92090-6_35-2
-
Original
Cell-Derived Exosome-Based Materials for Biomedical Applications- Published:
- 03 August 2023
DOI: https://doi.org/10.1007/978-3-030-92090-6_35-1